Regenovue Sub-Q Plus Lidocaine 1,1ml (1 syringe x 1,1ml)

Regenovue Sub-Q Plus Lidocaine 1.1ml (1 syringe x 1.1ml)

Regenovue Sub-Q Plus Lidocaine is a high-quality dermal filler designed to address deep wrinkles and enhance facial volume. Formulated with cross-linked hyaluronic acid and lidocaine, it ensures effective results with minimal discomfort during the procedure.

Product Features

• High-Quality Hyaluronic Acid: Contains 24mg/ml of non-animal based, cross-linked hyaluronic acid, ensuring biocompatibility and longevity of results.
• Incorporated Lidocaine: Includes 0.3% lidocaine to minimize pain and enhance patient comfort during treatment.
• Monophasic Structure: Features a homogeneous gel with consistent particle size, providing stability and precise application for facial contouring.
• Low Endotoxin Level: Boasts an endotoxin level of less than 0.0015 IU/mg, ensuring a high safety profile.
• Long-Lasting Effects: Results typically last between 8 to 12 months, depending on individual factors and treatment areas.

Indications

Regenovue Sub-Q Plus Lidocaine is suitable for:

• Correction of deep to severe wrinkles and folds, such as nasolabial folds and marionette lines.
• Facial volumization, including enhancement of cheeks, chin, and jawline.
• Nose augmentation and improvement of facial contours.
• Lip augmentation for increased volume and definition.

Technical Specifications

• Hyaluronic Acid Concentration: 24mg/ml
• Lidocaine Concentration: 0.3%
• Injection Depth: Lower subcutaneous layer
• Needle Size: 27G
• Duration of Effect: Approximately 8 to 12 months
• Storage Temperature: 2–25°C
• Shelf Life: 24 months
• CE Certification: Yes

Package Contents

Each package includes:

• 1 pre-filled syringe containing 1.1ml of Regenovue Sub-Q Plus Lidocaine
• 2 sterile 27G needles
• Package insert with detailed instructions
• Traceability labels

Usage Instructions

Regenovue Sub-Q Plus Lidocaine should be administered by licensed medical professionals trained in dermal filler injections. The product is injected into the lower subcutaneous layer using appropriate techniques for the treatment area. Injection sites should be determined based on individual patient needs and desired outcomes.

Safety Information

Common side effects may include temporary redness, swelling, or bruising at the injection sites, typically resolving within a few days. This product is contraindicated for individuals with known hypersensitivity to hyaluronic acid, lidocaine, or amide-type local anesthetics, those with active skin infections, and pregnant or breastfeeding women. Proper aseptic techniques must be followed to minimize the risk of infection.

Manufacturer Details

Brand: Regenovue

Manufacturer: NeoGenesis Co., Ltd.

Country of Origin: South Korea

Certification: CE-marked medical device